IGFBP-2 also upregulates PD-L1, and facilitates nuclear EGFR accumulation [91]; thus it may be hypothesized that the targeting of IGFBP-2 by miR-873 is also implicated in both stemness and chemoresistance in breast cancer. Here, IGFBP2 is linked to breast carcinoma.